• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

包裹在阳离子脂质体中的紫杉醇可减少“人源化”SCID小鼠模型中的肿瘤血管生成和黑色素瘤生长。

Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model.

作者信息

Kunstfeld Rainer, Wickenhauser Georg, Michaelis Uwe, Teifel Michael, Umek Wolfgang, Naujoks Kurt, Wolff Klaus, Petzelbauer Peter

机构信息

Department of Dermatology, Division of General Dermatology, University of Vienna Medical School, Vienna, Austria.

出版信息

J Invest Dermatol. 2003 Mar;120(3):476-82. doi: 10.1046/j.1523-1747.2003.12057.x.

DOI:10.1046/j.1523-1747.2003.12057.x
PMID:12603862
Abstract

Paclitaxel is an alkaloid that inhibits endothelial cell proliferation, motility, and tube formation at nanomolar concentrations. Cationic liposome preparations have been shown to target blood vessels. We wished to explore the possibility that paclitaxel encapsulated in cationic liposomes carries paclitaxel to blood vessels and thereby provides an antiangiogenic effect. We used a humanized SCID mouse melanoma model, which allowed us to analyze tumor growth and tumor angiogenesis in an orthotopic tumor model. Here, human melanoma cells grow on human dermis and are in part nourished by human vessels. We show that paclitaxel encapsulated in liposomes prevents melanoma growth and invasiveness and improves survival of mice. Moreover, liposome-encapsulated paclitaxel reduces vessel density at the interface between the tumor and the human dermis and reduces endothelial cell mitosis to background levels. In contrast, equimolar concentrations of paclitaxel solubilized in Cremophor EL(R) had only insignificant effects on tumor growth and did not reduce the mitotic index of endothelium in vivo, although the antiproliferative effect of solubilized paclitaxel in Cremophor EL(R)in vitro was identical to that seen with liposome-coupled paclitaxel. In conclusion, we present a model of how to exploit cytotoxic effects of compounds to prevent tumor growth by using cationic liposomes for targeting an antiproliferative drug to blood vessels.

摘要

紫杉醇是一种生物碱,在纳摩尔浓度下可抑制内皮细胞增殖、运动及血管生成。阳离子脂质体制剂已被证明可靶向血管。我们希望探究包裹在阳离子脂质体中的紫杉醇是否能将其携带至血管,从而产生抗血管生成作用。我们使用了人源化SCID小鼠黑色素瘤模型,该模型使我们能够在原位肿瘤模型中分析肿瘤生长和肿瘤血管生成。在此模型中,人黑色素瘤细胞在人真皮上生长,部分由人体血管提供营养。我们发现,包裹在脂质体中的紫杉醇可抑制黑色素瘤生长和侵袭,并提高小鼠存活率。此外,脂质体包裹的紫杉醇可降低肿瘤与人真皮界面处的血管密度,并将内皮细胞有丝分裂减少至背景水平。相比之下,等摩尔浓度的溶解在聚氧乙烯蓖麻油中的紫杉醇对肿瘤生长的影响微不足道,且在体内并未降低内皮细胞的有丝分裂指数,尽管溶解在聚氧乙烯蓖麻油中的紫杉醇在体外的抗增殖作用与脂质体偶联的紫杉醇相同。总之,我们展示了一种利用化合物的细胞毒性作用来预防肿瘤生长的模型,即通过使用阳离子脂质体将抗增殖药物靶向血管。

相似文献

1
Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model.包裹在阳离子脂质体中的紫杉醇可减少“人源化”SCID小鼠模型中的肿瘤血管生成和黑色素瘤生长。
J Invest Dermatol. 2003 Mar;120(3):476-82. doi: 10.1046/j.1523-1747.2003.12057.x.
2
Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin.阳离子脂质体包裹的紫杉醇可增加肿瘤微血管通透性,并与顺铂联合使用时提高治疗效果。
Clin Cancer Res. 2008 Jul 15;14(14):4603-11. doi: 10.1158/1078-0432.CCR-07-4738.
3
Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature.新生血管靶向化疗:紫杉醇包裹于阳离子脂质体中可破坏肿瘤微血管功能。
Int J Cancer. 2004 May 20;110(1):117-24. doi: 10.1002/ijc.20083.
4
Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.聚乙二醇包被的阳离子脂质体包裹的奥沙利铂,通过双靶向方法在小鼠实体瘤模型中显著抑制肿瘤生长。
J Control Release. 2009 Jul 1;137(1):8-14. doi: 10.1016/j.jconrel.2009.02.023. Epub 2009 Mar 12.
5
Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model.聚乙二醇化阳离子脂质体靶向血管生成血管的奥沙利铂抑制背气囊小鼠模型中的血管生成。
J Control Release. 2009 Feb 20;134(1):18-25. doi: 10.1016/j.jconrel.2008.10.018. Epub 2008 Nov 5.
6
Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance imaging.包裹在阳离子脂质复合物(MBT - 0206)中的紫杉醇会损害功能性肿瘤血管特性,这是通过动态对比增强磁共振成像检测到的。
Cancer Biol Ther. 2006 Jan;5(1):89-96. doi: 10.4161/cbt.5.1.2346. Epub 2006 Jan 22.
7
Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy.新生血管靶向治疗:阳离子脂质体包裹的紫杉醇可提高抗肿瘤疗效。
Clin Cancer Res. 2003 Jun;9(6):2335-41.
8
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.多种化疗药物用于节拍化疗的抗血管生成效力
Anticancer Res. 2004 May-Jun;24(3a):1759-63.
9
Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.脂质体磷酸泼尼松龙对小鼠B16黑色素瘤的抗血管生成作用。
J Control Release. 2006 Jun 12;113(1):1-8. doi: 10.1016/j.jconrel.2006.03.019. Epub 2006 Apr 7.
10
Paclitaxel encapsulated in cationic liposomes: a new option for neovascular targeting for the treatment of prostate cancer.阳离子脂质体包裹的紫杉醇:一种用于前列腺癌治疗的新的新生血管靶向选择。
Oncol Rep. 2009 Aug;22(2):321-6.

引用本文的文献

1
"Nano-Paclitaxel" Unlocking Potential and Redefining Cancer Chemotherapy.“纳米紫杉醇”:释放潜能,重新定义癌症化疗
ACS Omega. 2025 Jun 27;10(27):28670-28690. doi: 10.1021/acsomega.5c02916. eCollection 2025 Jul 15.
2
A Library of Custom PEG-Lipids reveals a Double-PEG-Lipid with Drastically Enhanced Paclitaxel Solubility and Human Cancer Cell Cytotoxicity when used in Fluid Micellar Nanoparticles.一个定制聚乙二醇脂质文库揭示了一种双聚乙二醇脂质,当用于流体胶束纳米颗粒时,其可使紫杉醇溶解度和对人癌细胞的细胞毒性大幅增强。
bioRxiv. 2024 Aug 3:2024.08.01.606138. doi: 10.1101/2024.08.01.606138.
3
Lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes.
具有负自发曲率的脂质会降低脂质体中癌症药物紫杉醇的溶解度。
Eur Phys J E Soft Matter. 2023 Dec 15;46(12):128. doi: 10.1140/epje/s10189-023-00388-2.
4
Lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes.具有负自发曲率的脂质会降低抗癌药物紫杉醇在脂质体中的溶解度。
bioRxiv. 2023 Oct 21:2023.10.18.563006. doi: 10.1101/2023.10.18.563006.
5
Implications of Axis Inhibition Protein 2 in Breast Cancer Progression.轴抑制蛋白 2 在乳腺癌进展中的意义。
In Vivo. 2023 Mar-Apr;37(2):634-643. doi: 10.21873/invivo.13122.
6
Paclitaxel-Loaded Cationic Fluid Lipid Nanodiscs and Liposomes with Brush-Conformation PEG Chains Penetrate Breast Tumors and Trigger Caspase-3 Activation.载紫杉醇的阳离子流体脂质纳米碟和具有刷形构象聚乙二醇链的脂质体穿透乳腺肿瘤并触发 caspase-3 激活。
ACS Appl Mater Interfaces. 2022 Dec 28;14(51):56613-56622. doi: 10.1021/acsami.2c17961. Epub 2022 Dec 15.
7
Risk Factors of Microscopically Tumor-Free Surgical Margins for Recurrence and Survival of Oral Squamous Cell Carcinoma Patients.口腔鳞状细胞癌患者复发和生存的显微镜下无肿瘤手术切缘的危险因素
Front Oncol. 2022 Jul 7;12:930988. doi: 10.3389/fonc.2022.930988. eCollection 2022.
8
Implication of COPB2 Expression on Cutaneous Squamous Cell Carcinoma Pathogenesis.COPB2表达在皮肤鳞状细胞癌发病机制中的意义。
Cancers (Basel). 2022 Apr 18;14(8):2038. doi: 10.3390/cancers14082038.
9
Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics.阳离子脂质体作为核酸和疏水性药物治疗的载体
Pharmaceutics. 2021 Aug 30;13(9):1365. doi: 10.3390/pharmaceutics13091365.
10
Paclitaxel loading in cationic liposome vectors is enhanced by replacement of oleoyl with linoleoyl tails with distinct lipid shapes.用具有不同脂质形状的亚油酸酯取代油酰酯,可增强阳离子脂质体载体中的紫杉醇负载。
Sci Rep. 2021 Mar 31;11(1):7311. doi: 10.1038/s41598-021-86484-9.